US 10350228
Treatment of sickle cell disease and inflammatory conditions
granted A61KA61K31/7004A61K31/7024
Quick answer
US patent 10350228 (Treatment of sickle cell disease and inflammatory conditions) held by Regents of the University of Minnesota expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7004, A61K31/7024, A61K31/7048, A61P